Cassava Sciences Inc financial data

Symbol
SAVA on Nasdaq
Location
6801 N Capital Of Texas Highway, Building 1; Suite 300, Austin, TX
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2025 - May 8, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 499 % +7.34%
Debt-to-equity 9.41 % +159%
Return On Assets -38 % -34.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 48.3M shares +11.8%
Common Stock, Shares, Outstanding 48.3M shares +11.7%
Entity Public Float 558M USD -42.3%
Common Stock, Value, Issued 48K USD +11.6%
Weighted Average Number of Shares Outstanding, Basic 48.3M shares +12.2%
Weighted Average Number of Shares Outstanding, Diluted 48.3M shares +9.43%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 67.1M USD -19.7%
General and Administrative Expense 79M USD +399%
Operating Income (Loss) -146M USD -47%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -72.8M USD -51.9%
Earnings Per Share, Basic -2 USD/shares -37.1%
Earnings Per Share, Diluted -2 USD/shares +30.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 117M USD -5.51%
Other Assets, Current 162K USD -25.7%
Assets, Current 120M USD -10.3%
Property, Plant and Equipment, Net 20.8M USD -3.81%
Operating Lease, Right-of-Use Asset 0 USD -100%
Intangible Assets, Net (Excluding Goodwill) 37K USD -79%
Assets 141M USD -9.5%
Accounts Payable, Current 10.3M USD +117%
Employee-related Liabilities, Current 855K USD +275%
Accrued Liabilities, Current 7.04M USD +112%
Liabilities, Current 13.2M USD -82.8%
Operating Lease, Liability, Noncurrent 0 USD -100%
Other Liabilities, Noncurrent 79K USD
Liabilities 13.3M USD
Retained Earnings (Accumulated Deficit) -429M USD -20.5%
Stockholders' Equity Attributable to Parent 128M USD +62.4%
Liabilities and Equity 141M USD -9.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -11.3M USD +40.7%
Net Cash Provided by (Used in) Financing Activities 90K USD -99.6%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 120M shares 0%
Common Stock, Shares, Issued 48.3M shares +11.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 189M USD +32.8%
Deferred Tax Assets, Valuation Allowance 96.7M USD +25%
Deferred Tax Assets, Gross 96.7M USD +25%
Depreciation 861K USD -23.3%
Payments to Acquire Property, Plant, and Equipment 0 USD
Property, Plant and Equipment, Gross 24.2M USD +0.39%
Operating Lease, Liability, Current 0 USD -100%
Deferred Tax Assets, Operating Loss Carryforwards 43.1M USD +29.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 9.24M USD +9.85%
Operating Lease, Payments 0 USD -100%
Additional Paid in Capital 556M USD +28%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 180K USD -59.6%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 19.2M USD +207%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%